Nemaura Medical Financials
| NMRDDelisted Stock | USD 0.08 0.01 12.09% |
With this module, you can analyze Nemaura financials for your investing period. You should be able to track the changes in Nemaura Medical individual financial statements over time to develop the understanding of its risk, liquidity, profitability, or other critical and vital indicators.
Nemaura |
Understanding current and past Nemaura Medical Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Nemaura Medical's financial statements are interrelated, with each one affecting the others. For example, an increase in Nemaura Medical's assets may result in an increase in income on the income statement.
The data published in Nemaura Medical's official financial statements usually reflect Nemaura Medical's business processes, product offerings, services, and other fundamental events. But there are other numbers, ratios, or fundamental indicators derived from these statements that are easier to understand and visualize within the underlying realities that drive quantitative information of Nemaura Medical. For example, before you start analyzing numbers published by Nemaura accountants, it's critical to develop an understanding of what Nemaura Medical's liquidity, profitability, and earnings quality are in the context of the Health Care Equipment & Supplies space in which it operates.
Please note, the presentation of Nemaura Medical's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, Nemaura Medical's management is honest, while the outside auditors are strict and uncompromising. Whatever the case, the imprecision that can be found in Nemaura Medical's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Nemaura Medical. Please utilize our Beneish M Score to check the likelihood of Nemaura Medical's management manipulating its earnings.
Nemaura Medical Stock Summary
Nemaura Medical competes with Neuropace, CVRx, Orthofix Medical, Artivion, and Bluejay Diagnostics. Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes diagnostic medical devices. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. Nemaura Med operates under Medical Devices classification in the United States and is traded on NASDAQ Exchange. It employs 32 people.Specialization | Healthcare, Medical Devices |
| Instrument | USA Stock View All |
| Exchange | NASDAQ Exchange |
| ISIN | US6404422080 |
| CUSIP | 640442208 640442109 |
| Location | New York; U.S.A |
| Business Address | 57 West 57th |
| Sector | Health Care Equipment & Supplies |
| Industry | Health Care |
| Benchmark | NYSE Composite |
| Website | nemauramedical.com |
| Phone | 646 416 7912 |
| Currency | USD - US Dollar |
You should never invest in Nemaura Medical without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Nemaura Stock, because this is throwing your money away. Analyzing the key information contained in Nemaura Medical's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Nemaura Medical Key Financial Ratios
Generally speaking, Nemaura Medical's financial ratios allow both analysts and investors to convert raw data from Nemaura Medical's financial statements into concise, actionable information that can be used to evaluate the performance of Nemaura Medical over time and compare it to other companies across industries. There are many critical financial ratios that investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Nemaura Medical reports annually and quarterly.Nemaura Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Nemaura Medical's current stock value. Our valuation model uses many indicators to compare Nemaura Medical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Nemaura Medical competition to find correlations between indicators driving Nemaura Medical's intrinsic value. More Info.Nemaura Medical is rated below average in return on equity category among related companies. It is rated below average in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value Nemaura Medical by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Nemaura Medical's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Nemaura Medical's earnings, one of the primary drivers of an investment's value.Nemaura Medical Market Pulse
| Quote | 0.08 |
| Change(%) | 12.09 |
| Change | 0.01 |
| Open | 0.091 |
| Low | 0.068 |
| High | 0.091 |
| Volume | 0 |
| Exchange | NASDAQ |
About Nemaura Medical Financials
What exactly are Nemaura Medical Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include Nemaura Medical's income statement, its balance sheet, and the statement of cash flows. Potential Nemaura Medical investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although Nemaura Medical investors may use each financial statement separately, they are all related. The changes in Nemaura Medical's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Nemaura Medical's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.Steps to analyze Nemaura Medical Financials for Investing
There are several different ways that investors can use financial statements to try and predict whether a stock price will go up or down. Unfortunately, there is no surefire formula, but there are some general guidelines you should consider when looking at the numbers. First, realize what kind of company it is so you know if its revenues are more likely to grow or shrink over time. For example, a software company's revenue is expected to increase yearly due to new products and services that its customers will want to buy. At the same time, a car manufacturer might not be able to sell as many cars when the economy slows down, so it would have less net income during those times. Second, pay attention to its debt-to-equity ratio because this number will tell you how much risk it has. If a company such as Nemaura Medical is not taking on any additional risks, its debt-to-equity should be less than one. As a general rule of thumb, if the market value or book value (which can be found in the footnotes) of assets exceeds the company's liabilities, then it is probably in good shape. Finally, use other financial statements to determine if a stock price will go up or down because investors are always looking for growth opportunities when they buy new stocks. For example, if you see that the net revenue of Nemaura has grown by more than 25% over the last five years, then there is a good chance that it will continue growing by at least 20% or more each year. On the other hand, if you see that net revenue has only increased by about 15%, which is barely above inflation levels, then chances are it will not grow much faster than this over time, and investors may shy away from buying it. In summary, you can determine if Nemaura Medical's financials are consistent with your investment objective using the following steps:- Review Nemaura Medical's balance sheet accounts, such as liabilities and equity, to understand its overall financial position.
- Analyze the income statement and examine the company's revenue, expenses, and profits over time to determine its financial performance.
- Study the cash flow inflows and outflows to understand Nemaura Medical's liquidity and solvency.
- Look at the growth rates in revenue, earnings, and cash flow over time to determine its potential for future growth.
- Compare Nemaura Medical's financials to those of its peers to see how it stacks up and identify any potential red flags.
- Use valuation ratios to evaluate the company's financials using commonly used ratios such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-earnings before interest, taxes, depreciation, and amortization (EV/EBITDA) ratio to determine if Nemaura Medical's stock is overvalued or undervalued.
Check out Correlation Analysis to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.
Other Consideration for investing in Nemaura Stock
If you are still planning to invest in Nemaura Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Nemaura Medical's history and understand the potential risks before investing.
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas |